Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Researchers from MIT, Northeastern University, and Meta recently released a paper suggesting that large language models (LLMs) similar to those that power ChatGPT may sometimes prioritize sentence ...

Brits are a patient bunch - wasting 3% of their entire lives waiting in queues. Researchers analysed the times we wait in queues for supermarkets, post offices, bus stops, sports events, car parks and ...

Discusses AI Infrastructure Partnership and Major Data Center Lease with Anthropic and Fluidstack December 17, 2025 12:00 PM ...

WASHINGTON, Dec. 9 (Yonhap) -- A U.S. expert called Tuesday for the United States to flag China's installation of maritime structures in and around a jointly managed zone between South Korea and China ...

Education reform, political protests, healthcare costs, new housing and tariffs dominated statewide and national headlines ...

University at Buffalo spinout Auspex Medix advances AI-powered hearing test to help older adults thwart cognitive decline, Alzheimer’s.

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Suzanne is a content marketer, writer, and ...